IL-17 Exerts Anti-Apoptotic Effect via miR-155-5p Downregulation in Experimental Autoimmune Encephalomyelitis-Reference-Cited by-同舟云学术

IL-17 Exerts Anti-Apoptotic Effect via miR-155-5p Downregulation in Experimental Autoimmune Encephalomyelitis

Published:2017-10-23 Issue:3-4 Volume:63 Page:320-332
ISSN:0895-8696
Container-title:Journal of Molecular Neuroscience
language:en
Short-container-title:J Mol Neurosci

Author:

Ksiazek-Winiarek Dominika^ORCID,Szpakowski Piotr,Turniak Malgorzata,Szemraj Janusz,Glabinski Andrzej

Funder

Narodowe Centrum Nauki

Uniwersytet Medyczny w Lodzi

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,General Medicine

Link

http://link.springer.com/article/10.1007/s12031-017-0981-2/fulltext.html

Reference65 articles.

1. Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective 665microRNA target sites in mammalian mRNAs. Elife. 4. doi: 10.7554/eLife.05005

2. Albanesi C, Cavani A, Girolomoni G (1999) IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 162:494–502

3. Almeida RD et al (2005) Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 12:1329–1343. doi: 10.1038/sj.cdd.4401662

4. An JJ et al (2008) Distinct role of long 3′ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 134:175–187. doi: 10.1016/j.cell.2008.05.045

5. Antonsson B (2004) Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways. Mol Cell Biochem 256-257:141–155

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study;Scientific Reports;2023-11-09

2. miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson’s disease;Frontiers in Pharmacology;2022-11-15

3. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review;Inflammation Research;2022-10-29

4. The role of interleukin-17 in epilepsy;Epilepsy Research;2022-10

5. Cytokines and microRNAs in SARS-CoV-2: What do we know?;Molecular Therapy - Nucleic Acids;2022-09